Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Next Generation Sequencing of Esophageal Cytology for the Early Detection of Esophageal Cancer

NCT02890979 is registered in ClinicalTrials.gov with OHSU Knight Cancer Institute as lead sponsor.

NCT NCT02890979
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02890979 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Next Generation Sequencing of Esophageal Cytology for the Early Detection of Esophageal Cancer
Lead sponsor
OHSU Knight Cancer Institute
Phase
Not applicable
Overall status
Completed
Start date
August 3, 2016
Completion date
October 10, 2017
Enrollment
11 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

barrett esophagus, dysplasia, esophageal adenocarcinoma, esophageal squamous cell carcinoma, gastroesophageal reflux disease, metaplasia